Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3107)
All Articles published online
|
Sep 21, 2009 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Salama M, Lawrance IC. Stevens-Johnson syndrome complicating adalimumab therapy in Crohn’s disease. World J Gastroenterol 2009; 15(35): 4449-4452 [PMID: 19764100 DOI: 10.3748/wjg.15.4449] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i35/4449.htm |
| Number | Citing Articles |
| 1 |
Enrique Gómez, Maria Jose Torres, Cristobalina Mayorga, Miguel Blanca. Immunologic Evaluation of Drug Allergy. Allergy, Asthma & Immunology Research 2012; 4(5): 251 doi: 10.4168/aair.2012.4.5.251
|
| 2 |
Souichi Shiratori, Hiroyuki Ohhigashi, Shinichi Ito, Kazuhiro Kudo, Maki Adachi, Toshiyuki Minamimoto, Junji Kato, Yasue Osai, Yutaka Tsutsumi, Takanori Teshima. Late onset toxic epidermal necrolysis induced by mogamulizumab, an anti‐CC chemokine receptor 4 antibody for the treatment of adult T‐cell leukaemia/lymphoma. Hematological Oncology 2017; 35(1): 138 doi: 10.1002/hon.2242
|
| 3 |
Abraham Kwak, Sung Ae Kim, Hee Joung Choi. Toxic Epidermal Necrolysis complicating Infliximab therapy in Refractory Kawasaki disease. Keimyung Medical Journal 2020; 39(2): 83 doi: 10.46308/kmj.2020.00094
|
| 4 |
Anna Yuan, Sook-Bin Woo. Adverse Drug Events in the Oral Cavity. Dermatologic Clinics 2020; 38(4): 523 doi: 10.1016/j.det.2020.05.012
|
| 5 |
Jinan Q Mohammed, Zainab Mahmmod, Abdulsatar J Mathkhor. Adalimumab-Induced Erythema Multiforme in a Patient With Rheumatoid Arthritis: A Case Report. Cureus 2022; doi: 10.7759/cureus.21126
|
| 6 |
ID O’Neill, C Scully. Biologics in oral medicine: principles of use and practical considerations. Oral Diseases 2012; 18(6): 525 doi: 10.1111/j.1601-0825.2012.01919.x
|
| 7 |
Daniel C. Baumgart, Ulrike Grittner, Andrea Steingräber, Marina Azzaro, Sandra Philipp. Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: Experience from a consecutive cohort of inflammatory bowel disease patients. Inflammatory Bowel Diseases 2011; 17(12): 2512 doi: 10.1002/ibd.21643
|
| 8 |
Břetislav Lipový, Jakub Holoubek. Current perspective on the role of TNFα inhibitors in treating patients with toxic epidermal necrolysis. Klinická farmakologie a farmacie 2016; 30(4): 24 doi: 10.36290/far.2016.031
|
| 9 |
Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 2010; 19(4) doi: 10.1002/pds.1849
|
| 10 |
Inês Marques, Ana Lagos, Jorge Reis, António Pinto, Beatriz Neves. Reversible Henoch–Schönlein purpura complicating adalimumab therapy. Journal of Crohn's and Colitis 2012; 6(7): 796 doi: 10.1016/j.crohns.2012.02.019
|
| 11 |
Dean Edwards, Eli Boritz, Edward W. Cowen, Ronald S. Brown. Erythema multiforme major following treatment with infliximab. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2013; 115(2): e36 doi: 10.1016/j.oooo.2012.08.001
|
| 12 |
Miranda Muhvić-Urek, Marija Tomac-Stojmenović, Brankica Mijandrušić-Sinčić. Oral pathology in inflammatory bowel disease. World Journal of Gastroenterology 2016; 22(25): 5655-5667 doi: 10.3748/wjg.v22.i25.5655
|
| 13 |
Marta Ferran Farrés. Efectos secundarios cutáneos de los fármacos antagonistas del factor de necrosis tumoral α. Piel 2012; 27(10): 558 doi: 10.1016/j.piel.2012.05.003
|
| 14 |
Joana Torres, Sébastien Buche, Emmanuel Delaporte, Jean-Frédéric Colombel. Skin Side Effects of Inflammatory Bowel Disease Therapy. Inflammatory Bowel Diseases 2013; 19(5): 1086 doi: 10.1097/MIB.0b013e3182802c07
|
| 15 |
Julio Ramírez, M. Victoria Hernández, Javier Galve, Juan D. Cañete, Raimon Sanmartí. Morphea associated with the use of adalimumab: a case report and review of the literature. Modern Rheumatology 2012; 22(4): 602 doi: 10.3109/s10165-011-0550-4
|
| 16 |
Debra F Eisenberg, Gregory W Daniel, Judith K Jones, Earl L Goehring, Peter M Wahl, Peter Winters, Jay Levin, Rhonda L Bohn. Validation of a claims‐based diagnostic code for Stevens–Johnson syndrome in a commercially insured population. Pharmacoepidemiology and Drug Safety 2012; 21(7): 760 doi: 10.1002/pds.3276
|
| 17 |
Eccard da Silva Ricardo, Garbi Novaes Alice, Bernarda Donato Göttems Leila, Rita Carvalho Garbi Novaes Maria. Risk factors for, and treatment of, Stevens-Johnson syndrome and toxic epidermal necrolysis: Evidence from the literature. African Journal of Pharmacy and Pharmacology 2018; 12(4): 61 doi: 10.5897/AJPP2017.4873
|
| 18 |
Julio Ramírez, M. Victoria Hernández, Javier Galve, Juan D. Cañete, Raimon Sanmartí. Morphea associated with the use of adalimumab: a case report and review of the literature. Modern Rheumatology 2012; 22(4): 602 doi: 10.3109/s10165-011-0550-4
|
| 19 |
Hui Li, Feng Tian. Toxic Epidermal Necrolysis Because of Various Herpesviruses Infection After Accelerated Infliximab Induction in a Chinese Patient With Acute Severe Ulcerative Colitis. Inflammatory Bowel Diseases 2020; 26(5): e38 doi: 10.1093/ibd/izaa034
|
| 20 |
S. Bhadresha, A. J. Hughes, L. McMahon, S. Reeken, N. Natkunarajah. Fixed drug eruption secondary to adalimumab. Clinical and Experimental Dermatology 2021; 46(2): 366 doi: 10.1111/ced.14400
|
| 21 |
Eleni A. Georgakopoulou, Crispian Scully. Orofacial adverse effects of biological agents. Journal of Investigative and Clinical Dentistry 2015; 6(4): 252 doi: 10.1111/jicd.12102
|
| 22 |
Jenny Roselli, Tommaso Innocenti, Erica Nicola Lynch, Laura Parisio, Pasquale Apolito, Tommaso Mello, Giuseppe Macrì, Monica Milla, Maria Rosa Biagini, Mirko Tarocchi, Stefano Milani, Andrea Galli. Stevens–Johnson Syndrome and Herpes Simplex Type 1 Infection during Adalimumab Therapy for Crohn’s Disease. Case Reports in Gastrointestinal Medicine 2020; 2020: 1 doi: 10.1155/2020/3875024
|
| 23 |
Muhammad Ali Shazib, Kevin M. Byrd, Ajay S. Gulati. Diagnosis and Management of Oral Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2022; 74(1): 7 doi: 10.1097/MPG.0000000000003302
|